Skip to main content
SpringerLink
Log in

Störungen der Pubertätsentwicklung

  • Chapter
Endokrinologie des Kindes- und Jugendalters

  • 46 Accesses

Zusammenfassung

Zeichen einer geschlechtlichen Entwicklung werden im Kindesalter spontan als krankhaft angesehen, so daß diese Kinder rasch in der Sprechstunde vorgestellt werden. Bleibt eine Reifeentwicklung zum durchschnittlich erwartbaren Zeitpunkt aus, entsteht bei Angehörigen wie bei den betroffenen Jungen und Mädchen selbst zwar weniger spontan, aber zunehmend das verunsichernde Gefühl, es könne eine körperliche Unzulänglichkeit oder gar eine krankhafte Störung vorliegen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Albright AL, Lee PA (1993) Neurosurgical treatment of hypothalamic hamartomas causing precocious puberty. J Neurosurg 78: 77–82

    PubMed  CAS  Google Scholar 

  2. Anasti JN, Flack MR, Froehlich J, Nelson LM, Nisula BC (1995) A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 80: 276–279

    PubMed  CAS  Google Scholar 

  3. Antoniazzi F, Cisternino M, Nizzoli G et al. (1994) Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments. Acta Paediatr 83: 1052–1056

    PubMed  CAS  Google Scholar 

  4. Antoniazzi F, Bertoldo F, Zamboni G et al. (1995) Bone mineral metabolism in girls with precocious puberty during gonadotropin-releasing hormone agonist treatment. Eur J Endocrinol 133: 412–417

    PubMed  CAS  Google Scholar 

  5. Arisaka O, Matsumoto T, Hosaka A et al. (1992) Cystic adult granulosa cell tumor causing precocious pseudo-puberty in a six-year-old girl. Acta Paediatr 81: 1061–1064

    PubMed  CAS  Google Scholar 

  6. Babovic-Vuksanovic D, Donaldson MDC, Gibson NA, Wallace AM (1994) Hazards of ketoconazole therapy in testotoxicosis. Acta Paediatr 83: 994–997

    PubMed  CAS  Google Scholar 

  7. Balducci R, Boscherini B, Mangiantini A, Morellini M, Toscano V (1994) Isolated precocious pubarche: an approach. J Clin Endocrinol Metab 79: 582–589

    PubMed  CAS  Google Scholar 

  8. Bar A, Linder B, Sobel EH, Saenger P, Dimartino-Nardi J (1995) Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr 126: 955–958

    PubMed  CAS  Google Scholar 

  9. Barnes ND, Hayles AB, Ryan RJ (1973) Maturation in juvenile hypothyreoidism. Mayo Clin Prog 48: 849

    CAS  Google Scholar 

  10. Berkovitz GD, Guerami A, Brown TR, MacDonald PC, Migeon CJ (1985) Familial gynecomastia with increased extraglandular aromatization of plasma carbon-19-steroids. J Clin Invest 75: 1763–1769

    PubMed  CAS  Google Scholar 

  11. Birkhäuser MH (1994) Treatment by pulsatile administration of GnRH in male hypogonadotropic hypogonadism. Prog Reprod Biol Med 16: 18–28

    Google Scholar 

  12. Birnbacher R, Wandl-Vergesslich K, Frisch H (1994) Diagnosis of X-recessive Kallmann syndrome in early infancy. Evidence of hypoplastic rhinencephalon. Eur J Pediatr 153: 245–247

    PubMed  CAS  Google Scholar 

  13. Biro FM, Lucky AW, Huster GA, Morrison JA (1990) Hormonal studies and physical maturation in adolescent gynecomastia. J Pediatr 116: 450–455

    PubMed  CAS  Google Scholar 

  14. Biskotti CV, Hart WR (1987) Juvenile granulosa cell tumors of the ovary. Arch Pathol Lab Med 113: 40–46

    Google Scholar 

  15. Boepple PA, Mansfield MJ, Wiermann ME et al. (1986) Use of a potent, long acting agonist of gonadotropinreleasing hormone in the treatment of precocious puberty. Endocr Rev 7: 24–33

    PubMed  CAS  Google Scholar 

  16. Bonneville JF, Cattin F (1995) The role of magnetic resonance imaging in the diagnosis of endocrine tumours of the sellar region in children. Horm Res 43: 151–153

    PubMed  CAS  Google Scholar 

  17. Boston BA, Mandel S, LaFranchi S, Bliziotes M (1994) Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing’s syndrome and nodular adrenal hyperplasia. J Clin Endocrinol Metab 79: 890–893

    PubMed  CAS  Google Scholar 

  18. Boulgourdjian E, Escobar ME, Martinez A, Heinrich JJ, Bergadâ C (1995) Bone age at discontinuation of medroxyprogesterone acetate therapy in girls with precocious puberty: effect on final height. Horm Res 44: 12–16

    PubMed  CAS  Google Scholar 

  19. Brauner R, Adan L, Malandry F, Zantleifer D (1994) Adult height in girls with idiopathic true precocious puberty. J Clin Endocrinol Metab 79: 415–420

    PubMed  CAS  Google Scholar 

  20. Brunelli VL, Chiumello G, David M, Forest MG (1995) Adrenarche does not occur in treated patients with congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 42: 461–466

    CAS  Google Scholar 

  21. Butenandt O (1983) Plasma-Prolaktin-Spiegel and Pubertätsgynäkomastie. Monatsschr Kinderheilkd 131: 455–457

    PubMed  CAS  Google Scholar 

  22. Butenandt O, Knorr D, Hecker W, Löhrs U (1980) Precocious puberty in a boy with hCG producing hepatoma. Hely Paediatr Acta 35: 155–158

    CAS  Google Scholar 

  23. Cacciari E, Cassio A, Balsamo A et al. (1994) Long-term follow-up and final height in girls with central precocious puberty treated with luteinizing hormone-releasing hormone analogue nasal spray. Am J Dis Child 148: 1194–1199

    CAS  Google Scholar 

  24. Carel J-C, Lahlou N, Guazzarotti L et al. (1995) Treat- 40. ment of central precocious puberty with depot leuprorelin. Eur J Endocrinol 132: 699–704

    PubMed  CAS  Google Scholar 

  25. Cavallo A, Richards GE, Busey S, Michaels SE (1995) A simplified gonadotropin-releasing hormone test for precocious puberty. Clin Endocrinol (Oxf) 42: 641–646

    CAS  Google Scholar 

  26. Chanson P, Dib A, Visot A, Derome PJ (1994) McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. Acta Endocrinol (Copenh) 131: 229–234

    CAS  Google Scholar 

  27. Clark PA, Clarke WL (1995) Testotoxicosis: an unusual presentation and novel gene mutation. Clin Pediatr (Phila) 34: 271–274 43.

    Google Scholar 

  28. Clemons RD, Kappy MS, Stuart TE, Perelman AH, Hoekstra FT (1993) Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty. Am J Dis Child 147: 653–657

    PubMed  CAS  Google Scholar 

  29. Comite F, Cassorla F, Barnes KM et al. (1986) LHRH analogue therapy for central precocious puberty. JAMA 255: 2613–2616

    PubMed  CAS  Google Scholar 

  30. Corpron CA, Black CT, Singletary SE, Andrassy RJ (1995) Breast cancer in adolescent females. J Pediatr Surg 30: 322–324

    CAS  Google Scholar 

  31. Costin G, Kershnar AK, Kogut MD, Turkington RW (1972) Prolactin activity in juvenile hypothyreoidism and precocious puberty. Pediatrics 50: 881

    PubMed  CAS  Google Scholar 

  32. Delemarre-van de Waal HA (1993) Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogona- 48. dism. Clin Endocrinol (Oxf) 38: 473–480

    Google Scholar 

  33. Dimartino-Nardi J, Wu R, Varner R, Wong WLT, Saenger P (1994) The effect of luteinizing hormone-releasing hormone analog for central precocious puberty on growth hormone (GH) and GH-binding protein. J Clin Endocrinol Metab 78: 664–668

    PubMed  CAS  Google Scholar 

  34. Duke VM, Winyard PJD, Thorogood P, Soothill P, Bouloux PMG, Woolf AS (1995) KAL, a gene mutated in Kallmann’s syndrome, is expressed in the first trimester of human development. Mol Cell Endocrinol 110: 73–79

    PubMed  CAS  Google Scholar 

  35. Eckert KL, Wilson DM, Bachrach LK et al. (1996) A single-sample, subcutaneous gonadotropin-releasing hormone test for central precocious puberty. Pediatrics 97: 517–519

    PubMed  CAS  Google Scholar 

  36. Egli CA, Rosenthal SM, Grumbach MM, Montalvo JM, Gondos B (1985) Pituitary gonadotropin independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis. J Pediatr 106: 33

    PubMed  CAS  Google Scholar 

  37. Ehrhardt AA, Meyer-Bahlburg HFL (1994) Psychosocial aspects of precocious puberty. Horm Res 41 (Suppl 2): 30–35

    PubMed  Google Scholar 

  38. Erickson GF, McLachlan RI, McClure N, Healy DL, Burger HG (1995) The Ovary: basic principles and concepts; A. Physiology, B. Clinical. In: Felig P, Baxter JD, Frohman LA (eds) Endocrinology and metabolism. McGraw-Hill, New York London Milan Toronto Tokyo Sydney, pp 973–1052

    Google Scholar 

  39. Feuillan PP, Jones J, Cutler GB Jr (1993) Long term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 77: 647–651

    PubMed  CAS  Google Scholar 

  40. Feuillan PP, Jones J, Ross JL (1995) Growth hormone hypersecretion in a girl with McCune-Albright syndrome: comparison with controls and response to a dose of long-acting somatostatin analog. J Clin Endocrinol Metab 80: 1357–1360

    PubMed  CAS  Google Scholar 

  41. Fontoura M, Brauner R, Prevot C, Rappaport R (1989) Precocious puberty in girls: early diagnosis of a slowly progressing variant. Arch Dis Child 64: 1170–1176

    PubMed  CAS  Google Scholar 

  42. Foster CM, Pescovitz OH, Comite F et al. (1985) Testolacton treatment of precocious puberty in McCune-Albright syndrome. Acta Endocrinol (Copenh) 109: 254–257

    CAS  Google Scholar 

  43. Freedman SM, Kreitzer PM, Elkowitz SS, Soberman N, Leonidas JC (1993) Ovarian microcysts in girls with isolated premature thelarche. J Pediatr 122: 246–249

    PubMed  CAS  Google Scholar 

  44. Freude S, Frisch H, Wimberger D et al. (1992) Septooptic dysplasia and growth hormone deficiency: accelerated pubertal maturation during GH therapy. Acta Paediatr Scand 81: 641–645

    CAS  Google Scholar 

  45. Frost GJ, Parkin JM, Scott D, Watson MJ (1985) Pseudo-precocious puberty caused by bilateral idiopathic testicular hyperplasia. Acta Paediatr Scand 74: 623

    PubMed  CAS  Google Scholar 

  46. Garcia MB, Koppeschaar HPF, Lips CJM, Thijssen JHH, Krenning EP (1994) Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: dynamic endocrine studies and treatment with the somatostatin analogue octreotide. J Endocrinol Invest 17: 59–65

    PubMed  CAS  Google Scholar 

  47. Garibaldi L (1995) Progression of premature thelarche to precocious puberty. J Pediatr 127: 336

    PubMed  CAS  Google Scholar 

  48. Garibaldi LR, Aceto T Jr, Weber C (1993) The pattern of gonadotropin and estradiol secretion in exaggerated thelarche. Acta Endocrinol (Copenh) 128: 345–350

    CAS  Google Scholar 

  49. Garibaldi LR, Aceto T Jr, Weber C, Pang S (1993) The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test. J Clin Endocrinol Metab 76: 851–856

    PubMed  CAS  Google Scholar 

  50. Genazzani AD, Massolo F, Ferrari E, Gandolfi A, Petraglia F, Genazzani AR (1996) Long-term GnRH-agonist administration revealed a GnRH-independent mechanism stimulating FSH discharge in humans. Eur J Endocrinol 134: 77–83

    PubMed  CAS  Google Scholar 

  51. Gessl A, Freissmuth M, Czech T et al. (1994) Growth hormone-prolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal GSa protein. J Clin Endocrinol Metab 79: 1128–1134

    PubMed  CAS  Google Scholar 

  52. Girard J, Baumann JB, Bühler U, Zuppinger K, Haas HG, Staub JJ, Wyss HI (1978) Cyproterone acetate: ACTH and adrenal function. J Clin Endocrinol Metab 41: 581–586

    Google Scholar 

  53. Greydanus DE, Parks DS, Farrel EG (1989) Breast disorders in children and adolescents. Pediatr Clin North Am 36: 601–638

    PubMed  CAS  Google Scholar 

  54. Griffin IJ, Cole TJ, Duncan KA, Hollman AS, Donaldson MDC (1995) Pelvic ultrasound findings in different forms of sexual precocity. Acta Paediatr 84: 544–549

    PubMed  CAS  Google Scholar 

  55. Grumbach MM, Kaplan SL (1988) Recent advances in the diagnosis and management of sexual precocity. Acta Paediatr Jap 30: 155–175

    Google Scholar 

  56. Grumbach MM, Styne DM (1992) Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In: Wilson JD, Foster DW (eds) Williams textbook of endocrinology. WB Saunders, Philadelphia London Toronto, pp 1139–1221

    Google Scholar 

  57. Haber HP, Wollmann HA, Ranke MB (1995) Pelvic ultrasonography: early differentiation between isolated premature thelarche and central precocious puberty. Eur J Pediatr 154: 182–186

    PubMed  CAS  Google Scholar 

  58. Habiby R, Silverman B, Listernick R, Charrow J (1995) Precocious puberty in children with neurofibromatosis type 1. J Pediatr 126: 364–367

    PubMed  CAS  Google Scholar 

  59. Hauffa BP (1990) Spezielle klinische Probleme - Pubertätsgynäkomastie. In: Stolecke H (Hrsg) Jugendmedizin. Enke, Stuttgart, S 30–36

    Google Scholar 

  60. Hauffa BP, Havers W, Stolecke H (1987) Short-term effects of testolacton compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with McCune Albright syndrome. Helv Paediatr Acta 42: 471–480

    PubMed  CAS  Google Scholar 

  61. Heinrich UE, Bolkenius M, Daum R, Oppermann HC, Mehls O, Brandis WE (1981) Virilizing hepatoblastoma - significance of alpha-l-fetoprotein and human chorionic gonadotropin as tumor markers in diagnosis and follow-up. Eur J Pediatr 135: 313–318

    PubMed  CAS  Google Scholar 

  62. Heinrichs C, Craen M, Vanderschueren-Lodeweyckx M, Malvaux P, Fawe L, Bourguignon JP (1994) Variations in pituitary-gonadal suppression during intranasal buserelin and intramuscular depot-triptorelin therapy for central precocious puberty. Acta Paediatr 83: 627–633

    PubMed  CAS  Google Scholar 

  63. Hertel NT, Stoltenberg M, Juul A et al. (1993) Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate. J Clin Endocrinol Metab 76: 924–927

    PubMed  CAS  Google Scholar 

  64. Holmes SJ, Shalet SM (1996) Role of growth hormone and sex steroids in achieving and maintaining normal bone mass. Horm Res 45: 86–93

    PubMed  CAS  Google Scholar 

  65. Hümmelink R, Oostdijk W, Partsch CJ, Odink RJH, Drop SLS, Sippell WG (1992) Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist decapeptyl-depot in children with central precocious puberty. Horm Metab Res 24: 122–126

    PubMed  Google Scholar 

  66. Huseman CA, Kelch RP, Hopwood NJ, Zipf WB (1978) Sexual precocity in association with septo-optic dysplasia and hypothalamic hypopituitarism. J Pediatr 92: 748–752

    PubMed  CAS  Google Scholar 

  67. Hyun Park K, Il Park W, Seok Lee B et al. (1994) Pulsatile gonadotrophin-releasing hormone therapy in patients with pituitary tumours treated by surgery and irradiation. Clin Endocrinol (Oxf) 40: 407–411

    Google Scholar 

  68. Ibanez L, Potau N, Zampolli M et al. (1994) Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test. J Clin Endocrinol Metab 78: 30–35

    PubMed  CAS  Google Scholar 

  69. Jones TH, Darne JF (1993) Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism. Clin Endocrinol (Oxf) 38: 203–208

    CAS  Google Scholar 

  70. Jones TH, Darne JF, McGarrigle HHG (1994) Diurnal rhythm of testosterone induced by human chorionic gonadotrophin (hCG) therapy in isolated hypogonadotrophic hypogonadism: a comparison between subcutaneous and intramuscular hCG administration. Acta Endocrinol (Copenh) 131: 173–178

    CAS  Google Scholar 

  71. Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebæk NE (1995) Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an anti-androgen (cyproterone acetate). J Clin Endocrinol Metab 80: 3059–3067

    PubMed  CAS  Google Scholar 

  72. Kadva A, Di WL, Djahanbakhch 0, Monson J, Silman R (1996) Evidence for the Bauman variant in Kallmann’s syndrome. Clin Endocrinol (Oxf) 44: 103–110

    CAS  Google Scholar 

  73. Kaplan SL, Grumbach MM (1990) Pathogenesis of sexual precocity. In: Grumbach MM, Sizonenko PC, Aubert ML (eds) Control of the onset of puberty. Williams & Wilkins, Baltimore, pp 620–660

    Google Scholar 

  74. Karnak I, Kotiloglu E, Tanyel FC, Hi[ccedil]sönmez A (1995) Axillary breast tissue in an adolescent girl. J Pediatr Surg 30: 1369

    PubMed  CAS  Google Scholar 

  75. Kletter GB, Kelch RP (1994) Clinical review 60: effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 79: 331–334

    PubMed  CAS  Google Scholar 

  76. Kliesch S, Behre HM, Nieschlag E (1994) High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. Acta Endocrinol (Copenh) 131: 347–354

    CAS  Google Scholar 

  77. Kobayashi Y, Murata A, Yasuda T et al. (1994) Suppression of sex steroids by a gonadotrophin-releasing hormone agonist increases serum growth hormone-binding protein activity in girls with central idiopathic precocious puberty. Clin Endocrinol (Oxf) 40: 351–355

    CAS  Google Scholar 

  78. König R, Schönberger W, Neumann P, Benes P, Grimm W (1987) Behandlung der ausgeprägten Pubertätsgynäkomastie mit Tamoxifen. Klin Pädiatr 199: 389–391

    PubMed  Google Scholar 

  79. Kraaij R, Post M, Kremer H et al. (1995) A missence mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab 80: 3168–3172

    PubMed  CAS  Google Scholar 

  80. Kremer H, Mariman E, Otten BJ et al. (1993) Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet 2: 1779–1783

    PubMed  CAS  Google Scholar 

  81. Large DM, Anderson DC (1979) Twenty-four hour profiles of circulating androgens and estrogens in male puberty with and without gynecomastia. Clin Endocrinol (Oxf) 11: 505–521

    CAS  Google Scholar 

  82. Large DM, Anderson DC, Laing I (1980) Twenty-four hour profiles of serum prolactin during male puberty with and without gynecomastia. Clin Endocrinol (Oxf) 12: 293–302

    CAS  Google Scholar 

  83. Latronico AC, Anasti J, Arnhold IJP et al. (1995) A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 80: 2490–2494

    CAS  Google Scholar 

  84. Laue L, Jones J, Barnes KM, Cutler GB Jr (1993) Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin. J Clin Endocrinol Metab 76: 151–155

    PubMed  CAS  Google Scholar 

  85. Lazar L, Kauli R, Bruchis C, Nordenberg J, Galatzer A, Pertzelan A (1995) High prevalence of abnormal adrenal response in girls with central precocious puberty at early pubertal stages. Eur J Endocrinol 133: 407–411

    PubMed  CAS  Google Scholar 

  86. Lazar L, Kauli R, Bruchis C, Nordenberg J, Galatzer A, Pertzelan A (1995) Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response. Eur J Endocrinol 133: 403–406

    PubMed  CAS  Google Scholar 

  87. Leitner C, Happ J, Kollmann F, Althoff PH (1986) Einleitung der Pubertät durch pulsatile Luteinisierungshormon Releasing Hormon (LHRH) Therapie bei einem Jungen mit Kallmann-Syndrom. Monatsschr Kinderheilkd 134: 138–141

    PubMed  CAS  Google Scholar 

  88. Leyendecker G, Wildt L (1984) Pulsatile Therapie der hypothalamischen Amenorrhö mit Gonadotropin-Releasing-Hormon. Dtsch Med Wochenschr 109: 462–465

    PubMed  CAS  Google Scholar 

  89. Likitmaskul S, Cowell CT, Donaghue K et al. (1995) ‘Exaggerated adrenarche’ in children presenting with premature adrenarche. Clin Endocrinol (Oxf) 42: 265–272

    CAS  Google Scholar 

  90. Lippe BM, Edwards MSB, Braunstein CD, Halks-Miller M (1984) A non-malignant teratoma secreting hCG: expanding the spectrum of ectopic hormone production. J Pediatr 105: 765

    PubMed  CAS  Google Scholar 

  91. Lorentzen D, Lawson L (1987) Selected sport bras: a biomechanical analysis of breast motion while jogging. Physiol Sports Med 5: 128–139

    Google Scholar 

  92. Luboshitzky R, Lavi S, Thuma I, Lavie P (1995) Increased nocturnal melatonin secretion in male patients with hypogonadotropic hypogonadism and delayed puberty. J Clin Endocrinol Metab 80: 2144–2148

    PubMed  CAS  Google Scholar 

  93. Luboshitzky R, Lavi S, Thuma I, Lavie P (1996) Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab 81: 770–774

    PubMed  CAS  Google Scholar 

  94. Lucky AW, Rich BH, Rosenfield RL, Fang VS, Roche-Binder NBA (1980) Bioactive LH: a test to discriminate true precocious puberty from premature thelarche and adrenarche. J Pediatr 97: 214–219

    PubMed  CAS  Google Scholar 

  95. Mahachoklertwattana P, Kaplan SL, Grumbach MM (1993) The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab 77: 118–124

    PubMed  CAS  Google Scholar 

  96. Malchoff CD, Reardon G, MacGillivray DC, Yamase H, Rogol AD, Malchoff DM (1994) An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs a-subunit from a bone lesion. J Clin Endocrinol Metab 78: 803–806

    PubMed  CAS  Google Scholar 

  97. Mansfield MJ, Rudlin CR, Crigler JF et al. (1988) Changes in growth and serum growth hormone and plasma somatomedin C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty. J Clin Endocrinol Metab 66: 3–9

    PubMed  CAS  Google Scholar 

  98. Marcondes JAM, Abujamra AC, Minanni SL et al. (1993) Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty. Horm Metab Res 25: 105–109

    PubMed  CAS  Google Scholar 

  99. Marilus R, Dickerman Z, Kaufmann H, Versano I, Laron Z (1981) Addison’s disease assiciated with precocious sexual development in a boy. Acta Paediatr Scand 70: 587–590

    PubMed  CAS  Google Scholar 

  100. Martul P, Pineda J, Levilliers J et al. (1995) Hypogonadotrophic hypogonadism with hyposmia, X-linked ichthyosis, and renal malformation syndrome. Clin Endocrinol (Oxf) 42: 121–128

    CAS  Google Scholar 

  101. Matsumoto AM (1994) Hormonal therapy of male hypogonadism. Endocrinol Metabol Clin North Am 23: 857–875

    CAS  Google Scholar 

  102. Menken KU, Roll C (1993) Bloody nipple discharge in a 3-year-old girl. Eur J Pediatr 152: 1047

    PubMed  CAS  Google Scholar 

  103. Miller JD, Brownell MD, Shaw A (1990) Bilateral breast masses and bloody nipple discharge in a 4-year-old boy. J Pediatr 116: 744–747

    PubMed  CAS  Google Scholar 

  104. Moore DC, Schlaepfer LV, Paunier L, Sizonenko PC (1984) Hormonal changes during puberty: V. Transient pubertal gynecomastia: abnormal androgen-estrogen ratios. J Clin Endocrinol Metab 58: 492–499

    PubMed  CAS  Google Scholar 

  105. Mullis PE, Wagner JK (1995) Molecular biology and its application in paediatric endocrinology. Eur J Pediatr 154 (Suppl 4): 530–539

    Google Scholar 

  106. Murram D, Dewhurst J, Grant DB (1983) Premature menarche: a follow-up study. Arch Dis Child 58: 142

    PubMed  CAS  Google Scholar 

  107. Nahoul K, Kottler M-L (1992) Relationships between androgen and estrogen sulfates in breast cyst fluid. Clin Chim Acta 209: 179–187

    PubMed  CAS  Google Scholar 

  108. Nakamura M, Okabe I, Itoh K (1994) Ovarian micro-cysts with premature thelarche. J Pediatr 124: 993

    PubMed  CAS  Google Scholar 

  109. Neely EK, Bachrach LK, Hintz RL et al. (1995) Bone mineral density during treatment of central precocious puberty. J Pediatr 127: 819–822

    PubMed  CAS  Google Scholar 

  110. O’Halloran DJ, Shalet SM (1994) A family pedigree exhibiting features of both multiple endocrine neoplasia type 1 and McCune-Albright syndromes. J Clin Endocrinol Metab 78: 523–525

    PubMed  Google Scholar 

  111. Oliveira SB, Donnadieu M, Chaussain JL (1993) Changes in growth hormone-binding protein in girls with central precocious puberty treated with a depot preparation of luteinizing hormone-releasing hormone analogue. Horm Res 39: 42–46

    PubMed  CAS  Google Scholar 

  112. O’Marcaigh AS, Ledger GA, Roche PC, Parisi JE, Zimmerman D (1995) Aromatase expression in human germinomas with possible biological effects. J Clin Endocrinol Metab 80: 3763–3766

    PubMed  Google Scholar 

  113. Oostdijk W, Hümmelink R, Odink RJH et al. (1990) Treatment of children with central precocious puberty by a slow-release gonadotropin releasing hormone agonist. Eur J Pediatr 149: 308–313

    PubMed  CAS  Google Scholar 

  114. Oppenheimer E, Linder B, Dimartino-Nardi J (1995) Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans. J Clin Endocrinol Metab 80: 614–618

    PubMed  CAS  Google Scholar 

  115. Partsch CJ, Hümmelink R, Lorenzen F, Sippell WG (1989) Deutsche Decapeptyl-Studiengruppe - Bedeutung and Charakteristika des LHRH-Tests in der Diagnostik der vorzeitigen Pubertätsentwicklung bei Mädchen: Der stimulierte LH/FSH-Quotient differenziert zwischen zentraler Pubertas praecox and praematurer Thelarche. Monatsschr Kinderheilkd 137: 284–288

    PubMed  CAS  Google Scholar 

  116. Partsch CJ, Hümmelink R, Peter M et al. (1993) Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. Horm Res 39: 111–117

    PubMed  CAS  Google Scholar 

  117. Partsch C-J, Weinbauer GF, Fang R, Nieschlag E (1995) Injectable testosterone undecanoate has more favourable pharmacokinetics and pharmacodynamics than testosterone enanthate. Eur J Endocrinol 132: 514–519

    PubMed  CAS  Google Scholar 

  118. Partsch CJ, Behre HM, Sippell WG, Nieschlag E (1997) Substitution mit Testosteron: Pharmakologische Aspekte und klinische Anwendung. In: Ranke MB, Stolecke H (Hrsg.). Pubertätsentwicklung. Ausgewählte Beiträge zu aktuellen klinisch-endokrinologischen Themen. Ankum-Kettenkamp, Dokument Bild: 129–177

    Google Scholar 

  119. Partsch CJ, Sippell WG (1997) Therapie der zentralen Pubertas praecox: GnRH-Agonisten mit und ohne Wachstumshormon. In: Ranke MB, Stolecke H (Hrsg.). Pubertätsentwicklung. Ausgewählte Beiträge zu aktuellen klinisch-endokrinologischen Themen. Ankum-Kettenkamp, Dokument Bild: 261–287

    Google Scholar 

  120. Pasquino AM (1995) Progression of premature thelarche to precocious puberty. Reply J Pediatr 127: 336–337

    Google Scholar 

  121. Pasquino AM, Tebaldi L, Cioschi L et al. (1985) Premature thelarche: a follow-up study of 40 girls. Arch Dis Child 60: 1180–1192

    PubMed  CAS  Google Scholar 

  122. Pasquino AM, Tebaldi L, Cives C, Maciocci M, Boscherini B (1987) Precocious puberty in the McCune-Albright syndrome. Acta Paediatr Scand 76: 841–843

    PubMed  CAS  Google Scholar 

  123. Pasquino AM, Cives C, Macciocci M, Tebaldi L, Musleh M, Boscherini B (1989) Transient true precocious puberty. A report of five cases. Eur J Pediatr 148: 735–736

    PubMed  CAS  Google Scholar 

  124. Pasquino AM, Pucarelli I, Passeri F, Segni M, Mancini MA, Municchi G (1995) Progression of premature thelarche to central precocious puberty. J Pediatr 126: 11–14

    PubMed  CAS  Google Scholar 

  125. Pasquino AM, Municchi G, Pucarelli I, Segni M, Mancini MA, Troiani S (1996) Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty. J Clin Endocrinol Metab 81: 948–951

    PubMed  CAS  Google Scholar 

  126. Paul D, Conte FA, Grumbach MM, Kaplan SL (1995) Long term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab 80: 546–551

    PubMed  CAS  Google Scholar 

  127. Pere A, Perheentupa J, Peter M, Voutilainen R (1995) Follow up of growth and steroids in premature adrenarche. Eur J Pediatr 154: 346–352

    PubMed  CAS  Google Scholar 

  128. Powell B (1983) Bicyclist’s nipples. N Engl J Med 249: 2457–2459

    CAS  Google Scholar 

  129. Prasher VP (1993) Familial precocious puberty in girls. J R Soc Med 86: 61

    PubMed  CAS  Google Scholar 

  130. Rieth KG, Comite F, Shaker TH, Cutler GB (1984) Pituitary and ovarian abnormalities demonstrated by CT and ultrasound in children with features of McCune-Albright syndrome. Radiology 153: 389–393

    PubMed  CAS  Google Scholar 

  131. Rime JL, Zumsteg U, Blumberg A, Hadziselimovic F, Girard J, Zurbrügg RP (1988) Long-term treatment of central precocious puberty with an intranasal LHRH analogue: control of pituitary function by urinary gonadotropins. Eur J Pediatr 147: 263–269

    PubMed  CAS  Google Scholar 

  132. Roger M, Chaussain JL, Berlier P et al. (1986) Longterm treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules. J Clin Endocrinol Metab 62: 670–677

    PubMed  CAS  Google Scholar 

  133. Rogers DA, Lobe TE, Rao BN et al. (1994) Breast malignancy in children. J Pediatr Surg 29: 48–51

    PubMed  CAS  Google Scholar 

  134. Ross JL, Pescovitz OH, Barnes K, Loriaux DL, Cutler GB (1987) Growth hormone secretory dynamics in children with precocious puberty. J Pediatr 110: 369–372

    PubMed  CAS  Google Scholar 

  135. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K (1995) Prevalence of carriers of premutation-size alleles of the FMRI gene and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 57: 1006–1018

    PubMed  CAS  Google Scholar 

  136. Saggese G, Bertelloni S, Baroncelli GI, Di Nero G, Battini R (1993) Growth velocity and serum aminoterminal propeptide of type III procollagen in precocious puberty during gonadotropin-releasing hormone analogue treatment. Acta Paediatr 82: 261–266

    PubMed  CAS  Google Scholar 

  137. Sandow J, von Rechenberg W (1997) LHRH-Agonisten und Antagonisten: Pharmakologie und klinische Anwendung. In: Ranke MB, Stolecke H (Hrsg.). Pubertätsentwicklung. Ausgewählte Beiträge zu aktuellen klinisch-endokrinologischen Themen. Ankum-Kettenkamp, Dokument Bild: 239–259

    Google Scholar 

  138. Santen RJ (1995) The Testis. In: Felig P, Baxter JD, Frohman LA (eds) Endocrinology and metabolism. McGraw-Hill, New York London Milan Tokyo Sydney Toronto, pp 885–972

    Google Scholar 

  139. Schedewie HK, Reiter EO, Beitins IZ et al. (1981) Testicular Leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab 52: 271

    PubMed  CAS  Google Scholar 

  140. Schroor EJ, Van Weissenbruch MM, Delemarre-van de Waal HA (1995) Long-term GnRH-agonist treatment does not postpone central development of the GnRH pusle generator in girls with idiopathic precocious puberty. J Clin Endocrinol Metab 80: 1696–1701

    PubMed  CAS  Google Scholar 

  141. Schwindinger WF, Levine MA (1993) McCune-Albright syndrome. Trends Endocrinol Metab 4: 238–242

    PubMed  CAS  Google Scholar 

  142. Sellers EP, MacGillivray MH (1995) Blunted adrenarche in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Res 21: 537–544

    PubMed  CAS  Google Scholar 

  143. Shenker A, Laue L, Kosugi S, Merendino JJ Jr., Minegishi T, Cutler GB Jr (1993) A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365: 652–654

    PubMed  CAS  Google Scholar 

  144. Shenker A, Weinstein LS, Moran A et al. (1993) Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein Gs. J Pediatr 123: 509–518

    PubMed  CAS  Google Scholar 

  145. Shenker A, Weinstein LS, Sweet DE, Spiegel AM (1994) An activating Gsa mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 79: 750–755

    PubMed  CAS  Google Scholar 

  146. Sippell WG (1994) Diagnosis and treatment of central precocious puberty - can final height be improved. Horm Res 41 (Suppl 2): 14–15

    PubMed  Google Scholar 

  147. Sklar CJ, Grumbach MM, Kaplan SL, Conte FA (1981) Hormonal and metabolic abnormalities associated with central nervous system germinoma in children and adolescents and the effect of therapy: report of ten patients. J Clin Endocrinol Metab 52: 9–14

    PubMed  CAS  Google Scholar 

  148. Sorgo W, Kiraly E, Haupenthal M et al. (1986) Precoci- 157. ous puberty (PP): effects on growth in patients treated with cyproterone acetate (CYP). Acta Endocrinol (Copenh) 111 (Suppl 274): 1

    Google Scholar 

  149. Stanhope R, Abdulwahid NA, Adams J, Brook CGD (1986) Studies of gonadotrophin pulsatility and pelvis 157a. ultrasound examinations distinguish between isolated premature thelarche and central precocious puberty. Eur J Pediatr 145: 190–194

    PubMed  CAS  Google Scholar 

  150. Stanhope R, Pringle PJ, Brook CGD (1988) Growth, growth hormone, and sex steroid secretion in girls with central precocious puberty treated with gonadotropin releasing hormone (GnRH) analogue. Acta Paediatr 159. Scand 77: 525–530

    CAS  Google Scholar 

  151. Starkesci PJ, Lee PA, Albright AL, Migeon CJ (1990) Hypothalamic hamartomas and sexual precocity - evaluation 160. of treatment options. Am J Dis Child 144: 225–228

    Google Scholar 

  152. Stasiowska B, Vannelli S, Benso L (1994) Final height in sexually precocious girls after therapy with an intrana- 161. sal analogue of gonadotrophin-releasing hormone (buserelin). Horm Res 42: 81–85

    PubMed  CAS  Google Scholar 

  153. Stier B, Ranke MB (1987) Pubertas praecox bei McCune-Albright Syndrom - Fallbericht and Literatur- 162. Übersicht. Klin Pädiatr 199: 376–381

    PubMed  CAS  Google Scholar 

  154. Stivel MS, Kauli R, Kaufman H, Laron Z (1982) Adrenocortical function in children with precocious sexual development during treatment with cyproterone acetate. Clin Endocrinol 16: 163–169

    CAS  Google Scholar 

  155. Stolecke H (1974) Therapeutische Anwendung von Thyreotropin-releasing-Hormon bei hypophysärem Minderwuchs mit sekundärer Hypothyreose. Monatsschr Kinderheilkd 122: 607

    PubMed  CAS  Google Scholar 

  156. Stolecke H, Andler W (1979) HCG-induced Leydig-cell refractoriness. XII. Acta Endocrinologica Congress, München, poster no 122

    Google Scholar 

  157. Styne DM, Harris DA, Egli CA et al. (1985) Treatment of 165. true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic ultrasound, and the hypothalamic- 166. pituitary-gonadal axis. J Clin Endocrinol Metab 61: 142–151

    PubMed  CAS  Google Scholar 

  158. Swaenepoel C, Chaussain JL, Roger M (1991) Longterm results of long-acting luteinizing-hormone-relea- 167. sing hormone agonist in central precocious puberty. Horm Res 36: 126–130

    PubMed  CAS  Google Scholar 

  159. Takahashi Y, Minamitani K, Kobayashi Y, Minagawa M, Yasuda T, Niimi H (1996) Spinal and femoral bone mass accumulation during normal adolescence: comparison 168. with female patients with sexual precocity and with hypogonadism. J Clin Endocrinol Metab 81: 1248–1253

    PubMed  CAS  Google Scholar 

  160. Tato L, Saggese G, Cavallo L et al. (1995) Use of combined GnRH agonist and hGH therapy for better attaining 169. the goals in precocious puberty treatment. Horm Res 44 (Suppl 3): 49–54

    PubMed  CAS  Google Scholar 

  161. Van Wyk JJ, Grumbach MM (1960) Syndrome of precocious menstruation and galactorrhea in juvenile hypothyreoidism: an example of hormonal overlap in pituitary feedback. J Pediatr 57: 416

    Google Scholar 

  162. Vicari E, Mongioì A, Calogero AE et al. (1992) Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism - long-term follow-up. Int J Androl 15: 320–329

    PubMed  CAS  Google Scholar 

  163. Werder EA, Mürset G, Zachmann M, Brook CGD, Prader A (1974) Treatment of precocious puberty with cyproterone acetate. Pediatr Res 8: 248–256

    PubMed  CAS  Google Scholar 

  164. Werder K von, Eversmann T (1984) Therapie des männlichen hypogonadotropen Hypogonadismus durch pulsatile GnRH-Applikation. Dtsch Med Wochenschr 109: 432–434

    Google Scholar 

  165. West KW, Rescorla FJ, Scherer LR III, Grosfeld JL (1995) Diagnosis and treatment of symptomatic breast masses in the pediatric population. J Pediatr Surg 30: 182–187

    PubMed  CAS  Google Scholar 

  166. Whitcomb RW, Crowley WF Jr (1993) Male hypogonadotropic hypogonadism. Endocrinol Metab Clin North Am 22: 125–143

    PubMed  CAS  Google Scholar 

  167. Wierman ME, Beardsworth DE, Crawford JD et al. (1986) Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche. J Clin Invest 77: 121–126

    PubMed  CAS  Google Scholar 

  168. Yano K, Hidaka A, Saji M et al. (1994) A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases. J Clin Endocrinol Metab 79: 1818–1823

    PubMed  CAS  Google Scholar 

  169. Yano K, Saji M, Hidaka A et al. (1995) A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocrinol Metab 80: 1162–1168

    PubMed  CAS  Google Scholar 

  170. Yen SSC (1993) Female hypogonadotropic hypogonadism: hypothalamic amenorrhea syndrome. Endocrinol Metab Clin North Am 22: 29–58

    PubMed  CAS  Google Scholar 

  171. Zachmann M (1991) Therapeutic indications for delayed puberty and hypogonadism in adolescent boys. Horm Res 36: 141–146

    PubMed  CAS  Google Scholar 

  172. Zachmann M, Eiholzer U, Muritano M, Werder EA, Manella B (1986) Treatment of pubertal gynecomastia with testolactone. Acta Endocrinol (Copenh) 279 (Suppl): 218–226

    CAS  Google Scholar 

  173. Zhang LH, Rodriguez H, Ohno S, Miller WL (1995) Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci USA 92: 10619–10623

    PubMed  CAS  Google Scholar 

  174. Zucchini S, Di Natale B, Ambrosetto P, De Angelis R, Cacciari E, Chiumello G (1995) Role of magnetic resonance imaging in hypothalamic-pituitary disorders. Horm Res 44 (Suppl 3): 8–14

    PubMed  CAS  Google Scholar 

  175. Zung A, Chalew SA, Schwindinger WF et al. (1995) Urinary cyclic adenosine 3’,5’-monophosphate response in McCune-Albright syndrome: clinical evidence for altered renal adenylate cyclase activity. J Clin Endocrinol Metab 80: 3576–3581

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Stolecke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Kinder- und Jugendmedizin, Klinikum der Universität Essen (GHS), Hufelandstraße 55, D-45122, Essen, Germany

    H. Stolecke (Ehem. Direktor der Abt. Pädiatrische Endokrinologie) (Ehem. Direktor der Abt. Pädiatrische Endokrinologie)

  2. Postfach 1302, D-49574, Ankum, Germany

    H. Stolecke (Ehem. Direktor der Abt. Pädiatrische Endokrinologie) (Ehem. Direktor der Abt. Pädiatrische Endokrinologie)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stolecke, H. (1997). Störungen der Pubertätsentwicklung. In: Stolecke, H. (eds) Endokrinologie des Kindes- und Jugendalters. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59043-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59043-6_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61855-3

  • Online ISBN: 978-3-642-59043-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation